The Product is administered to adults as follows.
Treatment of erosive esophagitis (EE): 40 mg is administered orally once a day for 4 weeks.
In the case of patients with untreated esophagitis or symptoms persisting, the administration is given for another 4 weeks. The Product can be administered with or without meals.
Other Services
Country
Account